Li Kang Biomedical Co., Ltd. (6242.TWO) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
Peer Comparison
About Li Kang Biomedical Co., Ltd.
—
Li Kang Biomedical Co., Ltd. is led by CEO Yu-Xiu Zheng, employs 130 people, headquartered in Tainan City, TW, publicly traded since 2007.
Li Kang Biomedical Co., Ltd. (6242.TWO) stock trades at $33.70 with a market capitalization of $1.07B. The stock is valued at a price-to-earnings (P/E) ratio of 14.12, price-to-book of 1.27, price-to-sales of 1.86. Over the past 52 weeks the stock has ranged between $33.50 and $40.10, and currently trades 16.0% below its 52-week high. It pays a dividend yielding 5.87%.
On profitability, Li Kang Biomedical Co., Ltd. generates a return on equity (ROE) of 9.12%, an operating margin of 16.70%, a net profit margin of 13.32%.
Official website: www.likangbio.com
Li Kang Biomedical Co., Ltd. (6242.TWO) — frequently asked questions
What is Li Kang Biomedical Co., Ltd. (6242.TWO) stock price today?
Li Kang Biomedical Co., Ltd. (6242.TWO) is currently trading at $33.70, down 0.59% today.
What is 6242.TWO P/E ratio?
Li Kang Biomedical Co., Ltd.'s P/E ratio is 14.12. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 6242.TWO return on equity (ROE)?
Li Kang Biomedical Co., Ltd.'s return on equity (ROE) is 9.12%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Li Kang Biomedical Co., Ltd.'s market cap?
Li Kang Biomedical Co., Ltd. has a market capitalization of $1.07B.
Does 6242.TWO pay a dividend?
Yes. Li Kang Biomedical Co., Ltd. currently yields 5.87%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 6242.TWO carry?
Li Kang Biomedical Co., Ltd. has a debt-to-equity ratio of 0.15. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 6242.TWO's profit margin?
Li Kang Biomedical Co., Ltd. reports a net profit margin of 13.32% — the share of revenue left after every cost, including tax and interest.
What sector is 6242.TWO in?
Li Kang Biomedical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 6242.TWO listed on?
Li Kang Biomedical Co., Ltd. trades on TWO under the ticker 6242.TWO.
What is 6242.TWO's 52-week range?
Over the last year Li Kang Biomedical Co., Ltd. has traded between $33.50 and $40.10.
Related — Stocks
Popular Stocks
Screens 6242.TWO currently matches
On the figures above, Li Kang Biomedical Co., Ltd. passes the filters for 20 of our ready-made screens, among them High Dividend Stocks, Dividend Stocks, Low Debt Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.